Research programme: Wnt signalling pathway inhibitors - The Genetics Company
Alternative Names: TGC-0011570; TGC-0011576; TGC-0011589; TGC-0012296Latest Information Update: 07 Jan 2011
At a glance
- Originator The Genetics Company
- Class Small molecules
- Mechanism of Action BCL9 protein inhibitors; PYGO2 protein inhibitors; Wnt signalling pathway inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 07 Jan 2011 Discontinued - Preclinical for Cancer in Switzerland (unspecified route)
- 15 Dec 2008 Preclinical development is ongoing in Switzerland
- 07 Dec 2007 Preclinical development is ongoing